î
îŒ
î
Mainz Biomed NV
MYNZ1.170USD
+0.020+1.74%
çµå€Â 12/24, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
4.79Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Mainz Biomed NV äŒæ¥å
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NVã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãMYNZ
äŒç€ŸåMainz Biomed NV
äžå Žæ¥Nov 04, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBaechler (Guido)
åŸæ¥å¡æ°19
蚌åžçš®é¡Ordinary Share
決ç®ææ«Nov 04
æ¬ç€Ÿæåšå°Sirius Gutenberg Park
éœåžMAINZ
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœGermany
éµäŸ¿çªå·55129
é»è©±çªå·496131265140
ãŠã§ããµã€ãhttps://www.mainzbiomed.com/
äŒæ¥ã³ãŒãMYNZ
äžå Žæ¥Nov 04, 2021
æé«çµå¶è²¬ä»»è
ãCEOãBaechler (Guido)
Mainz Biomed NVã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+6.65%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-0.84%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+1379.29%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
20.06K
+6.65%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
17.77K
-0.84%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+1379.29%
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
2.20K
--
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Sun, Nov 16
æŽæ°æå»: Sun, Nov 16
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Armistice Capital LLC
4.60%
Dauntless Investment Group, LLC
0.59%
Fur Wiederaufbau (Kredianstalt)
0.27%
Baechler (Guido)
0.23%
Hekland (Hans)
0.21%
ä»ã®
94.10%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Armistice Capital LLC
4.60%
Dauntless Investment Group, LLC
0.59%
Fur Wiederaufbau (Kredianstalt)
0.27%
Baechler (Guido)
0.23%
Hekland (Hans)
0.21%
ä»ã®
94.10%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Hedge Fund
4.60%
Investment Advisor
1.01%
Individual Investor
0.87%
ä»ã®
93.52%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Oct 1
æŽæ°æå»: Wed, Oct 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q3
32
386.03K
7.13%
+144.51K
2025Q2
35
323.69K
7.07%
-4.46K
2025Q1
40
350.55K
9.90%
-3.02K
2024Q4
40
356.23K
16.03%
+257.88K
2024Q3
37
115.45K
5.70%
+19.26K
2024Q2
34
120.95K
9.96%
+24.53K
2024Q1
36
122.04K
10.26%
+25.33K
2023Q4
27
96.56K
23.08%
+9.46K
2023Q3
22
91.42K
24.64%
+4.27K
2023Q2
22
91.39K
24.65%
+4.22K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Armistice Capital LLC
285.00K
5.27%
+88.40K
+44.96%
Jun 30, 2025
Dauntless Investment Group, LLC
50.00K
0.92%
+50.00K
--
Jun 30, 2025
Fur Wiederaufbau (Kredianstalt)
23.20K
0.43%
-7.74K
-25.00%
Sep 30, 2024
Baechler (Guido)
20.06K
0.37%
+1.25K
+6.65%
Mar 21, 2025
Hekland (Hans)
17.77K
0.33%
-151.00
-0.84%
Mar 21, 2025
Journey Advisory Group, LLC
15.00K
0.28%
+15.00K
--
Jun 30, 2025
Steward Partners Investment Advisory, LLC
10.00K
0.18%
+9.00K
+900.00%
Jun 30, 2025
Caragol (William J)
7.90K
0.15%
+2.58K
+48.56%
Mar 21, 2025
UBS Financial Services, Inc.
9.81K
0.18%
+7.90K
+413.24%
Jun 30, 2025
von Toerne (Chris)
2.50K
0.05%
+2.33K
+1379.29%
Mar 21, 2025
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
çš®é¡
æ¯ç
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
æ¥ä»
çš®é¡
æ¯ç
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
Nov 29, 2024
Merger
40â1
ãããã質å
Mainz Biomed NVã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îMainz Biomed NVã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ãã
Armistice Capital LLCã¯285.00Kæ ªãä¿æããŠãããããã¯å šäœã®5.27%ã«çžåœããŸãã
Dauntless Investment Group, LLCã¯50.00Kæ ªãä¿æããŠãããããã¯å šäœã®0.92%ã«çžåœããŸãã
Fur Wiederaufbau (Kredianstalt)ã¯23.20Kæ ªãä¿æããŠãããããã¯å šäœã®0.43%ã«çžåœããŸãã
Baechler (Guido)ã¯20.06Kæ ªãä¿æããŠãããããã¯å šäœã®0.37%ã«çžåœããŸãã
Hekland (Hans)ã¯17.77Kæ ªãä¿æããŠãããããã¯å šäœã®0.33%ã«çžåœããŸãã
Armistice Capital LLCã¯285.00Kæ ªãä¿æããŠãããããã¯å šäœã®5.27%ã«çžåœããŸãã
Dauntless Investment Group, LLCã¯50.00Kæ ªãä¿æããŠãããããã¯å šäœã®0.92%ã«çžåœããŸãã
Fur Wiederaufbau (Kredianstalt)ã¯23.20Kæ ªãä¿æããŠãããããã¯å šäœã®0.43%ã«çžåœããŸãã
Baechler (Guido)ã¯20.06Kæ ªãä¿æããŠãããããã¯å šäœã®0.37%ã«çžåœããŸãã
Hekland (Hans)ã¯17.77Kæ ªãä¿æããŠãããããã¯å šäœã®0.33%ã«çžåœããŸãã
Mainz Biomed NVã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯äœã§ããïŒ
îMainz Biomed NVã®æ ªäž»ã¿ã€ãäžäœ3çš®ã¯ã
Armistice Capital LLC
Dauntless Investment Group, LLC
Fur Wiederaufbau (Kredianstalt)
Armistice Capital LLC
Dauntless Investment Group, LLC
Fur Wiederaufbau (Kredianstalt)
Mainz Biomed NVïŒMYNZïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2025Q3æç¹ã§ãMainz Biomed NVã®æ ªåŒãä¿æããŠããæ©é¢ã¯32瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ386.03Kã§ãå
šäœã®7.13%ãå ããŠããŸãã2025Q2ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯0.06%å¢å ããŠããŸãã
Mainz Biomed NVã®æ倧ã®åçæºã¯äœã§ããïŒ
î--ã«ãããŠã--éšéãMainz Biomed NVã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯--ã§ãå
šåçã®--%ãå ããŠããŸãã
